IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Polaris Venture Management Co. V, L.L.C.

Q2 2014 Holdings

Filed 2014-08-11 | 5 holdings | $122.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Genocea Biosciences, Inc.Common Stock372427104$39.9K2,128,67832.5%
Bind Therapeutics, Inc.Common Stock05548N107$26.6K2,018,25321.7%
Trevena, Inc.Common Stock89532E109$21.5K3,811,68217.5%
Cerulean Pharma IncCommon Stock15708Q105$19.1K3,287,52915.5%
Fate Therapeutics, Inc.(FATE)Common Stock31189P102$15.6K2,473,18612.7%